Abstract

Brain positron emission tomography imaging with 18Fluorine-fluorodeoxyglucose (FDG-PET) has demonstrated utility in suspected autoimmune encephalitis. Visual and/or assisted image reading is not well established to evaluate hypometabolism/hypermetabolism. We retrospectively evaluated patients with autoimmune encephalitis between 2003 and 2018. Patients underwent EEG, brain magnetic resonance imaging (MRI), cerebrospinal fluid (CSF) sampling and autoantibodies testing. Individual FDG-PET images were evaluated by standard visual reading and assisted by voxel-based analyses, compared to a normal database. For the latter, three different methods were performed: two based on statistical surface projections (Siemens syngo.via Database Comparison, and 3D-SSP Neurostat) and one based on statistical parametric mapping (SPM12). Hypometabolic and hypermetabolic findings were grouped to identify specific patterns. We found six cases with definite diagnosis of autoimmune encephalitis. Two cases had anti-LGI1, one had anti-NMDA-R and two anti-CASPR2 antibodies, and one was seronegative. 18F-FDG-PET metabolic abnormalities were present in all cases, regardless of the method of analysis. Medial–temporal and extra-limbic hypermetabolism were more clearly depicted by voxel-based analyses. We found autoantibody-specific patterns in line with the literature. Statistical surface projection (SSP) methods (Neurostat and syngo.via Database Comparison) were more sensitive and localized larger hypermetabolic areas. As it may lead to comparable and accurate results, visual analysis of FDG-PET studies for the diagnosis of autoimmune encephalitis benefits from voxel-based analysis, beyond the approach based on MRI, CSF sample and EEG.

Highlights

  • Autoimmune encephalitis (AE) is an inflammatory disorder of the brain associated with neurologic dysfunction and is frequently a challenging diagnosis for the clinician

  • As it may lead to comparable and accurate results, visual analysis of FDG-PET studies for the diagnosis of autoimmune encephalitis benefits from voxel-based analysis, beyond the approach based on magnetic resonance imaging (MRI), cerebrospinal fluid (CSF) sample and EEG

  • Cognitive impairment was the first symptom in 5/6 cases with limbic encephalitis (LE) and behavioral changes were the first symptoms in the patient with anti-NMDA receptor encephalitis

Read more

Summary

Introduction

Autoimmune encephalitis (AE) is an inflammatory disorder of the brain associated with neurologic dysfunction and is frequently a challenging diagnosis for the clinician. Treatment in patients with LE is often delayed due to the lack of specific symptoms and the time it takes to obtain the result of the autoantibodies analysis. A new clinical approach was proposed to treat subjects with a high clinical suspicion of AE, including LE, potentially leading to better outcomes [3] This approach relies on neurological evaluation, brain magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) sampling to define possible AE. In these proposed guidelines, 18 FDG-PET is mentioned as an alternative to MRI, only for the diagnosis of definite AE [3]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call